TY - JOUR AU - Sung-Hyun Kim, AU - Dong-Wook Kim, PY - 2015/03/01 Y2 - 2024/03/19 TI - Comment on “Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors” JF - Haematologica JA - haematol VL - 100 IS - 3 SE - Online Only Articles DO - 10.3324/haematol.2014.123232 UR - https://haematologica.org/article/view/7320 SP - e120-e121 AB - ER -